The green tea-sourced MNCs loaded with an anticancer protein successfully demonstrated a much greater anticancer effect than the free protein in vitro and in vivo. This MNC offers the possibility of improved delivery of various therapeutic molecules that EGCG can bind to. It provides an additive therapeutic effect associated with the versatile green tea-sourced carrier.
展开▼